Gene Regulation Grants & Funding

• Research Home
>
• Laboratory Research
>
• Cancer Therapeutics Program
>
• Gene Regulation Laboratory
>
• Gene Regulation Grants & Funding

Gene Regulation Grants & Funding - Research at Peter Mac

Current Grants and Funding

NHMRC Project Grant: $168,750 p.a, ‘Defining the apoptotic and therapeutic activities of histone deacetylase inhibitors’, R.W. Johnstone, 2009–11. Prostate Cancer Foundation of Australia Concept Grant: $150,000 p.a, ‘Cell death and mobilizing immunity for the treatment of established prostate cancer’, R.W. Johnstone & M.J. Smyth. 2009-10. Novartis Collaborative Research Grant: $183,000 p.a. ‘Determining the effects of panobinostat on platelet production and survival’. R.W. Johnstone, H.M. Prince, S. Harrison. 2009–10. Victorian Cancer Agency Platform Technology Capacity Building Grant: $150,000 ‘Enhanced access to whole genome RNA interference screens through the Victorian Centre for Functional Genomics’. R.W Johnstone. 2009–10. Australian Cancer Research Foundation: $2.5 million. ‘Establishment of the ACRF Cancer Genomics Program’. R.W. Johnstone, D. Bowtell, R. Hannan, G McArthur, P. Humbert, D. Thomas, K. Simpson, V. Marshall, 2009. Victorian Breast Cancer Research Consortium (VBCRC) Translational Research Grant: $1,288,500, ‘Development and testing novel anti-breast cancer therapies’. R.W. Johnstone, M. Smyth, R. Hannan, R. Pearson, S. Loi. 2009–12. NHMRC Program Grant: $2.16 Million p.a., ‘Immune regulation, effector function and therapy’, R.W Johnstone, D.I. Godfrey, H.M. Prince, M.J. Smyth & J.A. Trapani. 2007–12. Susan G. Komen for the Cure Foundation (USA): $US200,000 p.a. 'Combination chemo-immunotherapy for established breast cancer', R.W. Johnstone, M. Smyth, 2008–10. Pfizer Australia Senior Research Fellowship for Assoc. R.W. Johnstone: $200,000 p.a., 2005–10. Cancer Research Institute (USA): $US450,000, 'Cancer Research Institute Pre-doctoral Emphasis Program in Tumour Immunology', R.W. Johnstone (Co-CI with MJ Smyth, J Trapani, D Godfrey, J McCluskey, W. Chen, A. Scott), 2008–11. Cure Cancer Australia Foundation Project Grant: $74,000, 'To develop a new project investigating whether an in vivo model of CLL can be established and utilised for pre-clinical testing of HDACi and ABT-737 combination therapy,' A. Alsop, 2009. Peter Mac Foundation Grant: $79,514, 'Continued development of the project aiming to establish an in vivo model of CLL and determine its utility for pre-clinical drug testing', A. Alsop, 2009. NHMRC Biomedical Career Development Award: $92,500pa, V. Solomon, 2009–12. Bioplatforms Access Voucher: $10,000, V. Solomon, 2009. Dutch Cancer Society: €333,600, 'Molecular characterisation of therapeutics in hepatocellular carcinoma', M. Bots, 2009–13.